THERAPEUTIC MODULATION OF THE TUMOR INFLAMMATORY RESPONSE

Details for Australian Patent Application No. 2002251754 (hide)

Owner BIOTHER CORPORATION

Inventors ROUSSEL, Eugene

Pub. Number AU-A-2002251754

PCT Pub. Number WO2002/055024

Priority 09/756,978 09.01.01 US

Filing date 9 January 2002

Wipo publication date 24 July 2002

Event Publications

6 February 2003 Application Open to Public Inspection

  Published as AU-A-2002251754

5 February 2004 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(f)/See Reg. 8.3(3). Examination has not yet been requested or directed for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002251755-Beta-lactamase substrates having phenolic ethers

2002251753-METAL-INFILTRATED POLYCRYSTALLINE DIAMOND COMPOSITE TOOL FORMED FROM COATED DIAMOND PARTICLES